New cases tested for RR-/MDR-TB in Europe (WHO region)

Europe (WHO region): New cases tested for RR-/MDR-TB was 88.0% in 2024. ▲ Rising

Latest (2024)
88.0%
Change on year
down 3.3%
Rank
3rd
of 11 groups
All-time high
99.0%
in 2017
All-time low
28.0%
in 2005
Years of data
20
2005–2024

New cases tested for RR-/MDR-TB in Europe (WHO region), 2005–2024

204060801002005201420242005: 282006: 302007: 542008: 522009: 722010: 662011: 672012: 762013: 842014: 962015: 892016: 892017: 992018: 912019: 892020: 912021: 922022: 922023: 912024: 88

Source: World Health Organization, Global Health Observatory.

Analysis

In 2024, new cases tested for rr-/mdr-tb in Europe (WHO region) stood at 88.0%.

The figure is down 3.3% on the previous year and down 8.3% over ten years.

Over the whole period, new cases tested for rr-/mdr-tb in Europe (WHO region) peaked at 99.0% in 2017 and was at its lowest, 28.0%, in 2005.

The long-run direction has been consistently rising across the 20 years of available data.

New cases tested for RR-/MDR-TB in Europe (WHO region), year by year

Annual values for New cases tested for RR-/MDR-TB (%) in Europe (WHO region), 2005 to 2024.
Year Value Change
2005 28.0%
2006 30.0% +7.1%
2007 54.0% +80.0%
2008 52.0% -3.7%
2009 72.0% +38.5%
2010 66.0% -8.3%
2011 67.0% +1.5%
2012 76.0% +13.4%
2013 84.0% +10.5%
2014 96.0% +14.3%
2015 89.0% -7.3%
2016 89.0% +0.0%
2017 99.0% +11.2%
2018 91.0% -8.1%
2019 89.0% -2.2%
2020 91.0% +2.2%
2021 92.0% +1.1%
2022 92.0% +0.0%
2023 91.0% -1.1%
2024 88.0% -3.3%

Averages by decade

DecadeAverage LowestHighest Years
2000s 47.2% 28.0% 72.0% 5
2010s 84.6% 66.0% 99.0% 10
2020s 90.8% 88.0% 92.0% 5

Countries ranked near Europe (WHO region)

  1. 1 Brunei Darussalam 100.0% compare
  2. 1 Fiji 100.0% compare
  3. 1 Seychelles 100.0% compare
  4. 1 Chile 100.0% compare
  5. 1 Montenegro 100.0% compare
  6. 1 Mauritius 100.0% compare
  7. 1 Slovenia 100.0% compare
  8. 1 Ecuador 100.0% compare
  9. 1 Barbados 100.0% compare
  10. 1 Eswatini 100.0% compare
  11. 1 Qatar 100.0% compare
  12. 1 Zimbabwe 100.0% compare
  13. 1 Bangladesh 100.0% compare
  14. 1 Lao People's Democratic Republic 100.0% compare
  15. 1 Armenia 100.0% compare
  16. 1 Iraq 100.0% compare
  17. 1 Costa Rica 100.0% compare
  18. 1 Albania 100.0% compare
  19. 1 Kuwait 100.0% compare
  20. 1 Oman 100.0% compare
  21. 1 Iceland 100.0% compare
  22. 1 Palau 100.0% compare
  23. 1 Bhutan 100.0% compare
  24. 1 New Zealand 100.0% compare
  25. 1 Afghanistan 100.0% compare
  26. 1 Benin 100.0% compare
  27. 1 Republic of Moldova 100.0% compare
  28. 1 Marshall Islands 100.0% compare
  29. 1 Belarus 100.0% compare
  30. 1 Samoa 100.0% compare
  31. 1 Lithuania 100.0% compare
  32. 1 Turkmenistan 100.0% compare
  33. 1 Jamaica 100.0% compare
  34. 1 Republic of Korea 100.0% compare
  35. 1 Morocco 100.0% compare
  36. 1 Belize 100.0% compare
  37. 1 Israel 100.0% compare
  38. 1 Antigua and Barbuda 100.0% compare
  39. 1 Eritrea 100.0% compare
  40. 1 Tonga 100.0% compare
  41. 1 Grenada 100.0% compare
  42. 1 Kazakhstan 100.0% compare
  43. 1 Ghana 100.0% compare
  44. 1 Togo 100.0% compare
  45. 1 Saint Vincent and the Grenadines 100.0% compare
  46. 1 Comoros 100.0% compare
  47. 1 Naoero 100.0% compare
  48. 1 Djibouti 100.0% compare
  49. 1 Saint Kitts and Nevis 100.0% compare

See the full ranking of 205 places →

More health data for Europe (WHO region)

All data for Europe (WHO region) →

Frequently asked questions

What is new cases tested for rr-/mdr-tb in Europe (WHO region)?
New cases tested for rr-/mdr-tb in Europe (WHO region) was 88.0% in 2024, according to World Health Organization, Global Health Observatory.
What is the highest new cases tested for rr-/mdr-tb recorded in Europe (WHO region)?
The highest recorded value was 99.0% in 2017.
What is the lowest new cases tested for rr-/mdr-tb recorded in Europe (WHO region)?
The lowest recorded value was 28.0% in 2005.
How does Europe (WHO region) rank for new cases tested for rr-/mdr-tb?
Europe (WHO region) ranks 3rd out of 11 groups with data for 2024.
Is new cases tested for rr-/mdr-tb rising or falling in Europe (WHO region)?
Over the last ten years it is down 8.3%. The long-run trend across the full record is rising.
Where does this Europe (WHO region) data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of New cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

New cases tested for RR-/MDR-TB in Europe (WHO region). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 08 September 2026, from https://health.statizoid.com/stat/new-cases-tested-for-rr-mdr-tb-percent/europe-who-region/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/new-cases-tested-for-rr-mdr-tb-percent/europe-who-region/">New cases tested for RR-/MDR-TB in Europe (WHO region)</a> — Statizoid

About this data

Indicator
New cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
205 places, 3,388 data points, 2005–2024
Last refreshed